Literature DB >> 16753417

Inadequate statistical power of negative clinical trials in urological literature.

Rodney H Breau1, Toby A Carnat, Isabelle Gaboury.   

Abstract

PURPOSE: Negative studies provide valuable information. However, conducting studies with inadequate power is unethical and an inefficient use of resources. The purpose of this study was to determine the prevalence of negative studies with inadequate power in urological literature.
MATERIALS AND METHODS: The Journal of Urology, Urology and BJU International (formerly British Journal of Urology) from 1982 to 2002 were searched using the Ovid MEDLINE database. All clinical trials that contained the phrase "no difference" were identified. Data necessary for power calculation were extracted from applicable studies.
RESULTS: Of the 417 articles identified in the MEDLINE search, 127 were negative studies that contained enough information to be analyzed. There were 70 (55%) articles from The Journal of Urology, 35 (28%) from BJU International and 22 (17%) from Urology. Of the studies that used continuous variables 65% had adequate power (greater than 80%) to detect a 50% difference between groups and 32% had adequate power to detect a 25% difference. Of the studies that used dichotomous variables only 33% had adequate power to detect a 50% difference between groups and 23% had adequate power to detect a 25% difference. Levels of adequate power in negative studies did not improve over time (p = 0.258).
CONCLUSIONS: Many negative studies in urological literature are inconclusive because they lack adequate power to detect even large differences between groups. Inadequately powered studies often result in false conclusions that alter clinical behavior and deter further research. Therefore, it is imperative to consider power when interpreting literature. When designing future investigations power calculations should be performed to ensure sufficient patient recruitment to attain clinically meaningful results.

Entities:  

Mesh:

Year:  2006        PMID: 16753417     DOI: 10.1016/S0022-5347(06)00505-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  Urinary tract obstruction: ureteral stents--weighing up the risks and benefits.

Authors:  Vincent G Bird; Philipp Dahm
Journal:  Nat Rev Urol       Date:  2011-12-13       Impact factor: 14.432

Review 2.  [Kaplan-Meier analysis in urological practice].

Authors:  M Rink; L A Kluth; S F Shariat; M Fisch; R Dahlem; P Dahm
Journal:  Urologe A       Date:  2013-06       Impact factor: 0.639

3.  Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot.

Authors:  Byron J Gajewski; Scott M Berry; Melanie Quintana; Mamatha Pasnoor; Mazen Dimachkie; Laura Herbelin; Richard Barohn
Journal:  Stat Med       Date:  2015-01-07       Impact factor: 2.373

4.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Peter C Gøtzsche; Douglas G Altman; Howard Mann; Jesse A Berlin; Kay Dickersin; Asbjørn Hróbjartsson; Kenneth F Schulz; Wendy R Parulekar; Karmela Krleza-Jeric; Andreas Laupacis; David Moher
Journal:  BMJ       Date:  2013-01-08

5.  [Confidence intervals and p-values in urology: interpretation and misinterpretation].

Authors:  M Rink; L A Kluth; S F Shariat; R Dahlem; M Fisch; P Dahm
Journal:  Urologe A       Date:  2013-04       Impact factor: 0.639

6.  Modeling and validating Bayesian accrual models on clinical data and simulations using adaptive priors.

Authors:  Yu Jiang; Steve Simon; Matthew S Mayo; Byron J Gajewski
Journal:  Stat Med       Date:  2014-11-06       Impact factor: 2.373

7.  "Positive" results increase down the Hierarchy of the Sciences.

Authors:  Daniele Fanelli
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

8.  Do pressures to publish increase scientists' bias? An empirical support from US States Data.

Authors:  Daniele Fanelli
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

9.  Re: Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification. T. Klatte, J. W. Said, M. de Martino, J. Larochelle, B. Shuch, J. Y. Rao, G. V. Thomas, F. F. Kabbinavar, A. S. Belldegrun and A. J. Pantuck. J Urol 2009; 181: 1558-1564.

Authors:  Rodney H Breau; John C Cheville; Christine M Lohse; Eugene D Kwon; Michael L Blute
Journal:  J Urol       Date:  2009-10-21       Impact factor: 7.450

10.  What every urologist should know about surgical trials Part II: What are the results and should I apply them to patient care?

Authors:  Sohail Bajammal; Mohit Bhandari; Philipp Dahm
Journal:  Indian J Urol       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.